Hostname: page-component-7479d7b7d-767nl Total loading time: 0 Render date: 2024-07-11T08:24:22.428Z Has data issue: false hasContentIssue false

Tuberculosis Contacts, Concerns, and Controls: What Matters for Healthcare Workers?

Published online by Cambridge University Press:  21 June 2016

Margarita E. Villarino*
Affiliation:
Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia
Gerald Mazurek
Affiliation:
Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia
*
Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, NCHSTP, MS E-10, Atlanta, GA30333 (MEV1@cdc.gov)
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2006

References

1.Cook, S, Maw, KL, Munsiff, SS, Fujiwara, PI, Frieden, TR. Prevalence of tuberculin skin test positivity and conversions among healthcare workers in New York City during 1994 to 2001. Infect Control Hosp Epidemiol 2003; 24:807813.CrossRefGoogle ScholarPubMed
2.Tokars, JI, McKinley, GF, Otten, J, et al. Use and efficacy of infection control practices at hospitals with previous outbreaks of multidrug-resistant tuberculosis. Infect Control Hosp Epidemiol 2001; 22:449455.CrossRefGoogle ScholarPubMed
3.Pocock, SJ. Clinical Trials: A Practical Approach. Bath, England: The Pittman Press; 1983.Google Scholar
4.Jensen, PA, Lambert, LA, Iademarco, MF, Ridzon, R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. Centers for Disease Control and Prevention. MMWR Recomm Rep 2005;54(RR-7):1141.Google Scholar
5.Mazuerk, GH, Jereb, J, Lobue, P, Iademarco, MF, Metchock, B, Vernon, A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention. MMWR Recomm Rep 2005; 54(RR-15):137.Google Scholar
6.Andersen, P, Munk, ME, Pollock, JM, Doherty, TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356:10991104.Google Scholar
7.Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000; 49(RR-6):151.Google Scholar
8.Gross, PA, Barrett, TL, Dellinger, EP, et al. Purpose of quality Standards for infectious diseases. Infectious Diseases Society of America. Clin Infect Dis 1994; 18:421.Google Scholar
9.US Department of Labor Bureau of Labor Statistics. Career guide to industries. Available at: http://www.bls.gov/oco/cg/cgs035.htm. Accessed March 22, 2006.Google Scholar
10.Nosocomial transmission of Mycobacterium tuberculosis found through screening for severe acute respiratory syndrome—Taipei, Taiwan, 2003. MMWR 2005; 54(RR-50):12801283.Google Scholar
11.Mycobacterium tuberculosis transmission in a newborn nursery and maternity ward—New York City, 2003. MMWR 2005; 54(RR-50):12801283.Google Scholar
12.Friedman, LN, Nash, ER, Bryant, J, et al. High rate of negative results of tuberculin and QuantiFERON tests among individuals with a history of positive skin test results. Infect Control Hosp Epidemiol 2006; 27:436441 (in this issue).CrossRefGoogle ScholarPubMed
13.Harada, N, Nakajima, Y, Higuchi, K, Sekiya, Y, Rothel, J, Mori, T. Screening for tuberculosis infection using whole-blood interferon-γ and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 2006; 27:442448 (in this issue).Google Scholar